Importantly, we also showed that SIRPγ is enriched in spheres of diverse cancer cell lines other than those derived from lung cancer and that its targeting also suppresses sphere formation and YAP signaling in a liver cancer cell line, suggesting that targeting SIRPγ may serve as a strategy for cancer other than lung cancer. This evidence concerns the gene SIRPG and cancer.